MENU
Logo Made in Germany BIO 2017

Hummingbird Diagnostics GmbH

Booth number: 4607-8

www.hummingbird-diagnostics.com
info@hb-dx.com

About us

Hummingbird Diagnostics is pioneering the development of novel miRNA-based liquid biopsy diagnostics for early disease detection of a broad range of indications. Our tests are performed using a liquid biopsy approach building on a track record of more than 7.000 clinical body fluid samples analyzed. 

The Company possesses a high-quality miRNA whole blood database supported by a strong IP portfolio. Based on this platform, we have selected an initial set of highly disease-specific miRNA biomarkers with remarkable extracellular stability and are currently developing a portfolio of proprietary diagnostic tests.
Hummingbird’s lead program for the early diagnosis of Stage I/II lung cancer from blood samples is currently under clinical evaluation.

Our long-term goal is to enable partners, doctors and patients to detect serious and life-threatening conditions earlier, in a simpler and more accurate fashion and improve clinical outcomes through earlier intervention.



Products and services

Hummingbird Diagnostics is using a liquid biopsy approach to generate miRNA biomarkers for diagnostics, drug discovery and safety.

The Company possesses a high-quality miRNA whole blood database supported by a strong IP portfolio.
Based on this platform, we are currently developing a portfolio of proprietary miRNA-based liquid biopsy diagnostics.
In addition, Hummingbird is offering its expertise and ISO-certified processes to 3rd parties who are interested in building diagnostics and therapeutics based on miRNAs from blood.
Hummingbird is an „Agilent Certified Services Provider” and accredited according to DIN EN ISO/IEC 17025:2005. 
We are looking for partners in the field of diagnostic and drug development.

DIAGNOSTIC DEVELOPMENT

  • Early diagnosis
  • Prognosis
  • Companion

ENHANCED CLINICAL DRUG DEVELOPMENT

  • Disease & treatment monitoring marker
  • Immunological status
  • Toxicological & adverse event marker

ACCESS TO IP PORTFOLIO

  • Dominant IP in whole blood
  • Out-licensing
  • Co-development

Contacts

Address
Hummingbird Diagnostics GmbH
Im Neuenheimer Feld 583
69120 Heidelberg
Germany

Phone: +49 6221 9143310
Fax: +49 6221 9143312

Jochen Kohlhaas
CEO
Phone: +49 6221 9143310
info@hb-dx.com

Representative
Hummingbird Diagnostics Inc.
139 America Boulevard
Ashland, MA 01721
USA


placrosse@hb-dx.com
www.hummingbird-diagnostics.com



Business matching
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.

Click here if you notice an image that violates copyright or privacy rights.

Your personal organizer

Your personal organizer

Print list  |  Save as PDF
Xell AG
Booth number: